This article only represents the author's own views.
Seven months.
That’s how much time medical device maker Broncus Holding Corp. (2216.HK) appears to have gained for itself from its new Hong Kong IPO that raised HK$1.55 billion ($200 million) last Friday. Based on its IPO prospectus filed back in May, the company looks like a classic underachiever just waiting to blossom when the world discovers its devices used to detect and treat lung diseases, including lung cancer.
您已閱讀8%（473字），剩餘92%（5536字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。